Roger D. Kornberg serves as Executive at Cocrystal Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Roger D. Kornberg has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 9, 2026 involved receiving (via award) 24,615 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | COCP | $0 | Award | 24,615 | $N/A | Discretionary |
Roger D. Kornberg currently holds 24,615 shares of Cocrystal Pharma, Inc. (COCP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roger D. Kornberg has been a net neutral trader of COCP stock. They have purchased $0 and sold $0 worth of shares.
Roger D. Kornberg's most recent insider trade was on Jan 9, 2026, when they sold 24,615 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted